Demonstration of a chronic myelogenous leukemia clone in acute myelogenous leukemia

被引:0
作者
Jeon, Byung Ryul [1 ]
Kim, Se Hyung [2 ]
Park, Sung Kyu [2 ]
Park, Rojin [3 ]
Hong, Dae Sik [2 ]
Lee, You Kyoung [1 ]
机构
[1] Soonchunhyang Univ, Dept Lab Med & Genet, Coll Med, Bucheon, South Korea
[2] Soonchunhyang Univ, Dept Internal Med, Coll Med, Div Hematol & Oncol, Bucheon, South Korea
[3] Soonchunhyang Univ, Dept Lab Med, Coll Med, Seoul, South Korea
来源
BIOMEDICAL RESEARCH-INDIA | 2016年 / 27卷 / 04期
关键词
AML; CML; BCR/ABL1; CD; 34; enrichment; Monosomy; 7; CHRONIC MYELOID-LEUKEMIA; ACUTE MYELOBLASTIC-LEUKEMIA; IMATINIB TREATMENT; PHILADELPHIA-CHROMOSOME; INTERFERON THERAPY; ABNORMALITIES; MONOSOMY-7; HEMATOPOIESIS; EMERGENCE; CELLS;
D O I
暂无
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
In the present study, we report a case of a 58-year-old female patient presenting with Philadelphia-chromosome (Ph)-negative blast cells and Ph-positive mature cells at diagnosis. The complete blood cell count showed the patient had a white blood cell count of 35.5 x 10(9)/L and a differential blast count of 62%. A bone marrow biopsy showed closely packed marrow with blast cell infiltration. Blasts were weakly positive for MPO stain, but negative for PAS and ANAE stains. Moreover, blasts tested positive for CD34, CD13, CD117, CD15, CD33, and CD7 and negative for TdT, CD3, CD22, and CD19 in cytometric immunophenotyping experiments. The patient, who had the karyotype 46, XX,t(9; 22) (q34; q11.2) [14]/45, XX, inv(3)(q21q26.2),-7[4], was therefore diagnosed as having AML. Fluorescence in situ hybridization (FISH) showed a decrease in Ph-positive clones and an increase in monosomy 7positive clones after CD34-positive cell enrichment, suggesting that the blasts were primarily Phnegative. This case highlights the necessity of analyzing the cytogenetic characteristics of blasts to better understand the nature of the disease when only a fraction of the cells are Ph-positive.
引用
收藏
页码:1099 / 1101
页数:3
相关论文
共 13 条
  • [1] Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority
    Bumm, T
    Müller, C
    Al-Ali, HK
    Krohn, K
    Shepherd, P
    Schmidt, E
    Leiblein, S
    Franke, C
    Hennig, E
    Friedrich, T
    Krahl, R
    Niederwieser, D
    Deininger, MWN
    [J]. BLOOD, 2003, 101 (05) : 1941 - 1949
  • [2] Emergence of new clonal abnormalities following interferon-alpha induced complete cytogenetic response in patients with chronic myeloid leukemia: Report of three cases
    Fayad, L
    Kantarjian, H
    OBrien, S
    Seong, D
    Albitar, M
    Keating, M
    Talpaz, M
    [J]. LEUKEMIA, 1997, 11 (05) : 767 - 771
  • [3] EVIDENCE FOR A MULTISTEP PATHOGENESIS OF CHRONIC MYELOGENOUS LEUKEMIA
    FIALKOW, PJ
    MARTIN, PJ
    NAJFELD, V
    PENFOLD, GK
    JACOBSON, RJ
    HANSEN, JA
    [J]. BLOOD, 1981, 58 (01) : 158 - 163
  • [4] Hyperleukocytotic secondary acute myeloid leukemia (AML) with sole monosomy 7 as sequela of Philadelphia-chromosome positive chronic myeloid leukemia (CML)
    Hackanson, Bjoern
    Rueckert, Anja
    Luebbert, Michael
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2009, 83 (06) : 611 - 612
  • [5] Myelodysplastic Syndrome with Ph Negative Monosomy 7 Chromosome following Transient Bone Marrow Dysplasia during Imatinib Treatment for Chronic Myeloid Leukemia
    Karimata, Kaori
    Masuko, Masayoshi
    Ushiki, Takashi
    Kozakai, Takashi
    Shibasaki, Yasuhiko
    Yano, Toshio
    Abe, Takashi
    Moriyama, Masato
    Toba, Ken
    Furukawa, Tatsuo
    Aizawa, Yoshifusa
    [J]. INTERNAL MEDICINE, 2011, 50 (05) : 481 - 485
  • [6] Philadelphia-negative clonal hematopoiesis following imatinib therapy in patients with chronic myeloid leukemia:: a report of nine cases and analysis of predictive factors
    Lin, Yulia
    Bruyere, Helene
    Horsman, Douglas E.
    Pantzar, Tapio
    Barnett, Michael J.
    Hogge, Donna E.
    Nevill, Thomas J.
    Nantel, Stephen H.
    Sutherland, Heather J.
    Toze, Cynthia L.
    Shepherd, John D.
    Lavoie, Julye C.
    Song, Kevin W.
    Smith, Clayton A.
    Forrest, Donna L.
    [J]. CANCER GENETICS AND CYTOGENETICS, 2006, 170 (01) : 16 - 23
  • [7] Clonally unrelated BCR-ABL-negative acute myeloblastic leukemia masquerading as blast crisis after busulphan and interferon therapy for BCR-ABL-positive chronic myeloid leukemia
    Manley, R
    Cochrane, J
    McDonald, M
    Rigby, S
    Moore, A
    Kirk, A
    Clarke, S
    Crossen, PE
    Morris, CM
    Patton, WN
    [J]. LEUKEMIA, 1999, 13 (01) : 126 - 129
  • [8] Monosomy 7 with severe myelodysplasia developing during imatinib treatment of Philadelphia-positive chronic myelold leukemia:: Two cases with a different outcome
    Navarro, Jose-Torns
    Feliu, Evarist
    Grau, Javier
    Espinet, Blanca
    Colorner, Dolors
    Ribera, Josep-Maria
    Oriol, Albert
    Granada, Isabel
    Junc, Jordi
    Milla, Fuensanta
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2007, 82 (09) : 849 - 851
  • [9] BCR-ABL1+ Acute Myeloid Leukemia: Clonal Selection of a BCR-ABL1- Subclone as a Cause of Refractory Disease with Nilotinib Treatment
    Neuendorff, Nina Rosa
    Schwarz, Michaela
    Hemmati, Philipp
    Tuerkmen, Seval
    Bommer, Christiane
    Burmeister, Thomas
    Doerken, Bernd
    le Coutre, Philipp
    Arnold, Renate
    Westermann, Joerg
    [J]. ACTA HAEMATOLOGICA, 2015, 133 (02) : 237 - 241
  • [10] ACUTE MYELOBLASTIC-LEUKEMIA WITHOUT PHILADELPHIA-CHROMOSOME DEVELOPING AFTER INTERFERON THERAPY FOR CHRONIC MYELOCYTIC-LEUKEMIA WITH PHILADELPHIA-CHROMOSOME
    OHTSUKA, E
    KIKUCHI, H
    ABE, Y
    MORIYAMA, K
    OHNO, E
    HIROTA, K
    TEZONO, K
    NASU, M
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1995, 90 (04) : 951 - 953